Ona Therapeutics (“Ona”), a global biotech company pioneering first-in-class antibody-drug conjugates (ADCs), today announced key leadership appointments to support its rapid growth and pipeline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback